Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +1.75% | +7.14% | -22.76% |
06/05 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.76% | 13Cr | |
+33.13% | 4.95TCr | |
+1.73% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+11.57% | 2.66TCr | |
-22.68% | 1.86TCr | |
+8.13% | 1.32TCr | |
+29.18% | 1.25TCr | |
+24.33% | 1.21TCr |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Wedbush Lifts Omega Therapeutics' Price Target to $25 From $24, Keeps Outperform Rating